IL173850A0 - Method for the in vitro titration of an ncta and application thereof in a method for the evaluation and/or monitoring of a biological product production method - Google Patents
Method for the in vitro titration of an ncta and application thereof in a method for the evaluation and/or monitoring of a biological product production methodInfo
- Publication number
- IL173850A0 IL173850A0 IL173850A IL17385006A IL173850A0 IL 173850 A0 IL173850 A0 IL 173850A0 IL 173850 A IL173850 A IL 173850A IL 17385006 A IL17385006 A IL 17385006A IL 173850 A0 IL173850 A0 IL 173850A0
- Authority
- IL
- Israel
- Prior art keywords
- ncta
- monitoring
- application
- evaluation
- vitro
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
- G01N33/6896—Neurological disorders, e.g. Alzheimer's disease
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
- G01N33/56983—Viruses
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Biomedical Technology (AREA)
- Chemical & Material Sciences (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Molecular Biology (AREA)
- Analytical Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Pathology (AREA)
- General Physics & Mathematics (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Cell Biology (AREA)
- Biochemistry (AREA)
- Tropical Medicine & Parasitology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Toxicology (AREA)
- Virology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Investigating Or Analyzing Non-Biological Materials By The Use Of Chemical Means (AREA)
Abstract
The invention relates to a method for the in vitro titration of a non-conventional transmissible agent (NCTA), using transgenic cell lines. The invention also relates to: the application of the aforementioned in vitro titration method in a method for the in vitro evaluation and/or monitoring of the effectiveness of a biological production or treatment method or of one or more steps in such a method for the elimination of an NCTA, and to the application thereof in a method for the in vitro evaluation and/or monitoring of a decontamination procedure.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR0310126A FR2859222B1 (en) | 2003-08-25 | 2003-08-25 | METHOD OF EVALUATING AND / OR CONTROLLING A PROCESS FOR OBTAINING A BIOLOGICAL PRODUCT LIKELY TO BE CONTAMINATED BY NON-CONVENTIONAL TRANSMISSIBLE AGENT (NCTA) |
PCT/FR2004/002179 WO2005022148A1 (en) | 2003-08-25 | 2004-08-23 | Method for the in vitro titration of an ncta and application thereof in a method for the evaluation and/or monitoring of a biological product production method |
Publications (2)
Publication Number | Publication Date |
---|---|
IL173850A0 true IL173850A0 (en) | 2006-07-05 |
IL173850A IL173850A (en) | 2012-02-29 |
Family
ID=34130588
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL173850A IL173850A (en) | 2003-08-25 | 2006-02-21 | Method for the in vitro titration of an ncta and application thereof in a method for the evaluation and/or monitoring of a biological product production method |
Country Status (12)
Country | Link |
---|---|
EP (1) | EP1658494B1 (en) |
JP (1) | JP2007503209A (en) |
AT (1) | ATE528646T1 (en) |
AU (1) | AU2004269188B2 (en) |
BR (1) | BRPI0413897A (en) |
CA (1) | CA2536688C (en) |
DK (1) | DK1658494T3 (en) |
ES (1) | ES2374816T3 (en) |
FR (1) | FR2859222B1 (en) |
IL (1) | IL173850A (en) |
PL (1) | PL1658494T3 (en) |
WO (1) | WO2005022148A1 (en) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2885369B1 (en) * | 2005-05-04 | 2010-11-12 | Lab Francais Du Fractionnement | PRION TYPE SYNTHETIC AND STANDARDIZED INFECTIOUS MATERIAL AND USES THEREOF AS INFECTING INOCULUM. |
FR2929290B1 (en) * | 2008-03-27 | 2010-05-07 | Lfb Biotechnologies | METHOD FOR IN VITRO DETECTION AND / OR TITRATION OF NON-CONVENTIONAL TRANSMISSIBLE AGENT |
FR2935711A1 (en) * | 2008-09-05 | 2010-03-12 | Lfb Biotechnologies | STABLE CELLULAR CLONE EXPRESSING A PRION |
FR2940446A1 (en) | 2008-12-22 | 2010-06-25 | Lfb Biotechnologies | METHOD OF DETECTING PRION INFECTION |
FR2998373B1 (en) | 2012-11-20 | 2015-01-09 | Franklab Sas | METHOD FOR MEASURING THE SUITABILITY OF A FORMULATION TO INACTIVATE AN ATNC |
FR3005576B1 (en) | 2013-05-15 | 2015-06-19 | Lab Francais Du Fractionnement | PROCESS FOR INACTIVATING A PRION PROTEIN |
CN111683737A (en) * | 2018-02-19 | 2020-09-18 | 拜耳医药保健有限公司 | Modified filtration membranes and methods |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6605445B1 (en) * | 1999-02-22 | 2003-08-12 | Bayer Corporation | Rapid method of determining clearance of prion protein |
-
2003
- 2003-08-25 FR FR0310126A patent/FR2859222B1/en not_active Expired - Fee Related
-
2004
- 2004-08-23 WO PCT/FR2004/002179 patent/WO2005022148A1/en active Application Filing
- 2004-08-23 CA CA2536688A patent/CA2536688C/en not_active Expired - Fee Related
- 2004-08-23 DK DK04786344.4T patent/DK1658494T3/en active
- 2004-08-23 JP JP2006524391A patent/JP2007503209A/en active Pending
- 2004-08-23 AT AT04786344T patent/ATE528646T1/en active
- 2004-08-23 BR BRPI0413897-0A patent/BRPI0413897A/en not_active IP Right Cessation
- 2004-08-23 ES ES04786344T patent/ES2374816T3/en not_active Expired - Lifetime
- 2004-08-23 PL PL04786344T patent/PL1658494T3/en unknown
- 2004-08-23 AU AU2004269188A patent/AU2004269188B2/en not_active Ceased
- 2004-08-23 EP EP04786344A patent/EP1658494B1/en not_active Expired - Lifetime
-
2006
- 2006-02-21 IL IL173850A patent/IL173850A/en not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
AU2004269188B2 (en) | 2011-04-07 |
CA2536688C (en) | 2012-11-06 |
JP2007503209A (en) | 2007-02-22 |
EP1658494B1 (en) | 2011-10-12 |
DK1658494T3 (en) | 2012-01-09 |
FR2859222A1 (en) | 2005-03-04 |
ATE528646T1 (en) | 2011-10-15 |
IL173850A (en) | 2012-02-29 |
BRPI0413897A (en) | 2006-10-24 |
FR2859222B1 (en) | 2006-01-27 |
EP1658494A1 (en) | 2006-05-24 |
ES2374816T3 (en) | 2012-02-22 |
WO2005022148A1 (en) | 2005-03-10 |
CA2536688A1 (en) | 2005-03-10 |
AU2004269188A1 (en) | 2005-03-10 |
PL1658494T3 (en) | 2012-05-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL173850A0 (en) | Method for the in vitro titration of an ncta and application thereof in a method for the evaluation and/or monitoring of a biological product production method | |
AU2003221270A8 (en) | Nanocomposites: products, process for obtaining them and uses thereof | |
WO2008053482A3 (en) | Application of magnetic field to treat tissue | |
EP1857195A4 (en) | Method of bending processing for metal material, bending processing apparatus, bending processing equipment line and bending-processed produced obtained thereby | |
WO2006099541A3 (en) | Therapeutic wound care product | |
TW200714283A (en) | Method and composition for treating peripheral vascular diseases | |
MX2009004986A (en) | Methods of treating hemolytic anemia. | |
WO2007026251A3 (en) | Use of dual c-kit/fgfr3 inhibitors for treating multiple myeloma | |
WO2006121684A3 (en) | Acyl hydrazones for treating cardiovascular diseases | |
HK1076095A1 (en) | Pentafluorosulfanyl-benzoylguanidine, method for the production thereof and its utilization as medicament or diagnostic agent and medicament containing same | |
MX2010001230A (en) | System, method and apparatus for processing bone product. | |
WO2003007803A3 (en) | Methods for diagnosing and treating alzheimer's disease and parkinson's disease | |
WO2009015369A3 (en) | Isophthalamide derivatives inhibiting beta-secretase activity | |
DE60033339D1 (en) | Method for monitoring the clock and device for data transmission, which uses the method | |
AU2003274186A1 (en) | Method for monitoring and analyzing a process | |
UA83203C2 (en) | Thiazol-(bi)cycloalkyl-carboxanilides and their use for fighting against undesirable microorganisms | |
WO2007067516A3 (en) | Multiple myeloma | |
TW200642688A (en) | New use of PDE7 inhibitors | |
WO2006078776A3 (en) | Inhibitors and methods of treatment of cardiovascular diseases, and methods for identifying inhibitors | |
DE502004011486D1 (en) | ANTIOXIDANT FOR ORGANIC MATERIAL AND METHOD FOR THE TREATMENT THEREOF | |
WO2004072296A3 (en) | Compositions for modulating immune cell activity and methods for detection thereof | |
DE10293412D2 (en) | Device and method for the detection of living microorganisms, eukaryotic cells or organelles | |
HK1060883A1 (en) | Chemical compounds. | |
MD20050153A (en) | Agent for extraroot nutrition and plant protection | |
HK1063480A1 (en) | Oil retention treatment agent, oil retention treatment method and the watch performed by the method |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FF | Patent granted | ||
KB | Patent renewed | ||
MM9K | Patent not in force due to non-payment of renewal fees |